Atezolizumab (MPDL3280A), an Engineered Anti-PD-L1 Antibody

Quiénes somos

  • noviembre 15, 2022
    Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer (STELLAR-303)